133 related articles for article (PubMed ID: 1854608)
1. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness.
Carnochan P; Briggs JC; Westbury G; Davies AJ
Br J Cancer; 1991 Jul; 64(1):102-7. PubMed ID: 1854608
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.
Srivastava A; Laidler P; Davies RP; Horgan K; Hughes LE
Am J Pathol; 1988 Nov; 133(2):419-23. PubMed ID: 3189515
[TBL] [Abstract][Full Text] [Related]
3. Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumour behaviour.
Srivastava A; Hughes LE; Woodcock JP; Laidler P
Br J Cancer; 1989 Jan; 59(1):89-91. PubMed ID: 2667611
[TBL] [Abstract][Full Text] [Related]
4. The vascularity of primary cutaneous melanoma.
Fallowfield ME; Cook MG
J Pathol; 1991 Jul; 164(3):241-4. PubMed ID: 1890549
[TBL] [Abstract][Full Text] [Related]
5. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study.
Srivastava A; Laidler P; Hughes LE; Woodcock J; Shedden EJ
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1205-9. PubMed ID: 2434333
[TBL] [Abstract][Full Text] [Related]
6. Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. A quantitative assay.
Rongioletti F; Miracco C; Gambini C; Pastorino A; Tosi P; Rebora A
Am J Dermatopathol; 1996 Oct; 18(5):474-7. PubMed ID: 8902093
[TBL] [Abstract][Full Text] [Related]
7. Tumour vascularity is not a prognostic factor for cutaneous melanoma.
Barnhill RL; Busam KJ; Berwick M; Blessing K; Cochran AJ; Elder DE; Fandrey K; Karaoli T; White WL
Lancet; 1994 Oct; 344(8931):1237-8. PubMed ID: 7934572
[No Abstract] [Full Text] [Related]
8. The significance of blood flow in cutaneous malignant melanoma demonstrated by Doppler flowmetry.
Srivastava A; Hughes LE; Woodcock JP; Shedden EJ
Eur J Surg Oncol; 1986 Mar; 12(1):13-8. PubMed ID: 2420648
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of vascularity in cutaneous melanoma: pilot study using in vivo confocal scanning laser microscopy.
Humphrey S; Walsh NM; Delaney L; Propperova I; Langley RG
J Cutan Med Surg; 2006; 10(3):122-7. PubMed ID: 17241587
[TBL] [Abstract][Full Text] [Related]
10. Vascular retardation in dormant growth-stunted malignant melanomas.
Piérard-Franchimont C; Henry F; Heymans O; Piérard GE
Int J Mol Med; 1999 Oct; 4(4):403-6. PubMed ID: 10493982
[TBL] [Abstract][Full Text] [Related]
11. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas.
Piérard GE; Piérard-Franchimont C
Eur J Cancer; 1997 Oct; 33(11):1888-92. PubMed ID: 9470852
[TBL] [Abstract][Full Text] [Related]
12. Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis.
Massi D; Franchi A; Borgognoni L; Paglierani M; Reali UM; Santucci M
Virchows Arch; 2002 Jan; 440(1):22-8. PubMed ID: 11942572
[TBL] [Abstract][Full Text] [Related]
13. Dermal vascularity in lentigo maligna.
Trotter MJ; Tron VA
J Pathol; 1994 Aug; 173(4):341-5. PubMed ID: 7525908
[TBL] [Abstract][Full Text] [Related]
14. Tumor vascularity in the prognostic assessment of primary cutaneous melanoma.
Kashani-Sabet M; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR
J Clin Oncol; 2002 Apr; 20(7):1826-31. PubMed ID: 11919240
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumour vascularity in primary melanoma.
Ilmonen S; Kariniemi AL; Vlaykova T; Muhonen T; Pyrhönen S; Asko-Seljavaara S
Melanoma Res; 1999 Jun; 9(3):273-8. PubMed ID: 10465583
[TBL] [Abstract][Full Text] [Related]
16. Preoperative assessment of tumour thickness and vascularity using high-frequency ultrasonography in ten cases of cutaneous melanoma.
Shobatake C; Miyagawa F; Ogawa K; Azukizawa H; Hirai T; Kuwahara M; Asada H
Eur J Dermatol; 2018 Apr; 28(2):256-258. PubMed ID: 29400300
[No Abstract] [Full Text] [Related]
17. Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance.
Döme B; Paku S; Somlai B; Tímár J
J Pathol; 2002 Jul; 197(3):355-62. PubMed ID: 12115882
[TBL] [Abstract][Full Text] [Related]
18. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin.
Busam KJ; Berwick M; Blessing K; Fandrey K; Kang S; Karaoli T; Fine J; Cochran AJ; White WL; Rivers J
Am J Pathol; 1995 Oct; 147(4):1049-56. PubMed ID: 7573350
[TBL] [Abstract][Full Text] [Related]
19. A study of the thickness of uninvolved dermis beneath cutaneous malignant melanoma: the ratio of uninvolved dermis to tumour thickness (DT:TT) as a prognostic index.
Saxby PJ; Griffiths RW; Corbishley CM; Briggs JC
Br J Plast Surg; 1984 Oct; 37(4):496-500. PubMed ID: 6498387
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen.
Guffey JM; Chaney JV; Stevens GL; Schroer KR; Fenske NA; Reintgen D; Glass LF
J Cutan Pathol; 1995 Apr; 22(2):122-7. PubMed ID: 7560343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
